Voloridge Investment Management, LLC Atara Biotherapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $689,430 - $1.02 Million	-49,245 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $623,934 - $1.29 Million	49,245 New	49,245 $967,000
Q3 2019 Nov 14, 2019	SELL	$12.03 - $19.94 $159,421 - $264,244	-13,252 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $252,450 - $543,862	13,252 New	13,252 $266,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.